Mr. Chair, I'll just add to that.
I don't dispute what's in the literature with regard to certain studies. I'll tell you that the challenge we have with any of these kinds of studies is that we need to have replicated trials with standardized protocols and standardized end points. I think that happens in the food area when we talk about clinical trials and the benefits of certain ingredients. We'll see results that may actually benefit the consumer, may have a neutral effect, or may even be detrimental. The problem is that we haven't standardized our protocols.